Baillie Gifford & CO Cooper Companies, Inc. Transaction History

Baillie Gifford & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$346.15 - $392.09 $767,760 - $869,655	-2,218 Reduced 7.42%	27,692 $10.6 Million
Q4 2022 Jan 24, 2023	SELL	$248.67 - $334.17 $363,804 - $488,890	-1,463 Reduced 4.66%	29,910 $9.89 Million
Q3 2021 Oct 19, 2021	SELL	$396.76 - $455.92 $685,998 - $788,285	-1,729 Reduced 5.22%	31,373 $13 Million
Q2 2021 Aug 02, 2021	SELL	$372.36 - $412.07 $967,391 - $1.07 Million	-2,598 Reduced 7.28%	33,102 $13.1 Million
Q4 2020 Feb 10, 2021	BUY	$319.05 - $363.32 $11.4 Million - $13 Million	35,700 New	35,700 $13 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.